| Financial Year |
March 31 2023 |
| Monetary Funds |
212,005,194.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
30,482,232.18 |
| Accounts Receivable |
105,245,456.64 |
| Advances to Suppliers |
66,495,125.49 |
| Other Receivables |
1,651,481.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
29,593,725.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,818,868.17 |
| Total Current Assets |
447,292,083.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
356,793.87 |
| Investment Properties |
-- |
| Fixed Assetes |
190,157,574.45 |
| Under-construction Projects |
88,252,331.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
80,017,714.59 |
| R&D expenses |
31,251,211.88 |
| Goodwill |
19,752,602.91 |
| Long-Term Deferred and Prepaid Expenses |
195,106.74 |
| Deferred Income Tax Assets |
198,134,827.95 |
| Other Non-Current Assets |
2,123,989.45 |
| Sub-Total of Non-Current Assets |
1,093,284,461.79 |
| Total Assets |
1,540,576,544.83 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
35,115,761.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,706,605.77 |
| Taxes Payable |
2,433,111.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,860,957.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,711,003.09 |
| Other Current Liabilities |
88,894,514.74 |
| Sub-Total of Current Liabilities |
182,632,919.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
47,027,538.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,609,882.10 |
| Total Liabilities |
265,242,801.64 |
| Paid-In Capital(Or Share Stock) |
475,357,555.00 |
| Capital Surplus |
519,359,672.79 |
| Surplus Reserve |
169,406,419.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
96,725,332.51 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,275,333,743.19 |
| Owner's Equity（Stockholder's Equity） |
1,275,333,743.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,540,576,544.83 |
